IP Library Granted Patent US 8,414,947
Granted Patent B2
US 8,414,947 · App. 11/817,266 · Granted Apr 9, 2013

Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter

Inventors: Malte Adelmann (Greifswald, DE); Dieter Fichtner (Greifswald, DE); Bodo Lange (Greifswald, DE); Werner Weitschies (Neuenkirchen, DE)
Assignee: Riemser Arzneimittel AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,414,947
App. No.
11/817,266
Granted
Apr 9, 2013
Kind
B2
Abstract

The present invention is directed to a pharmaceutical preparation for oral application for treatment of fish, in particular for vaccination of fish of the salmon family and other fish having a comparable digestive system against bacterial and/or viral infections, in particular against VHS and IHN. The invention is also directed to a method for producing the preparation.

Claims (7)

1. A method for producing an extruded pharmaceutical preparation for oral administration for vaccination of fish, comprising:

preparing a mixture of at least one active vaccine ingredient, at least one basic inorganic hydroxide component, and at least one carrier component; and

extruding the mixture into feed pellets of the extruded preparation via cold extrusion,

wherein the at least one active vaccine ingredient and the at least one basic inorganic hydroxide component are encapsulated by a matrix of the at least one carrier component via the cold extrusion to produce the extruded preparation, wherein the extruded preparation is formulated so as to disintegrate by at least 80% in an acidic environment in a stomach of a fish to be vaccinated.

2. The method according to claim 1 wherein the feed pellets are provided with a coating.

3. The method according to claim 2 , wherein the coating contains a talcum and/or a dye.

4. The method according to claim 2 , wherein the step of extruding is carried out at room temperature or a temperature below room temperature.

Assignments (2)
MERGER Recorded Jul 1, 2013
From: RIEMSER ARZNEIMITTEL AG
To: RIEMSER PHARMA GMBH
Reel/Frame 030744/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2007
From: ADELMANN, MALTE; FICHTNER, DIETER; LANGE, BODO; WEITSCHIES, WERNER
To: RIEMSER ARZNEIMITTEL AG
Reel/Frame 020221/0465 →
Priority Claims (1)
DE 10 2005 010 288 · Mar 2, 2005 · national
Continuity (1)
Related Publication 20080317825A1 · Dec 25, 2008